
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
Keywords: HBV; hepatitis B virus; RT; reverse transcriptase; Ns(t)RTI; nucleos(t)ide reverse transcriptase inhibitors; LMV; lamivudine; ETV; entecavir; TBV; telbivudine; ADV; adefovir; HBeAg; HBV e antigen; HBsAg; HBV s antigen; FDR; false discovery rate; IQR; inte